EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Non‐Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over‐the‐Counter Medications

Ewa Wunsch, Linda Krause, Ansgar Wilhelm Lohse, Christoph Schramm, Bernd Löwe, Natalie Uhlenbusch, Romée Snijders, José Willemse, Maciej Janik, Tom J G Gevers, Piotr Milkiewicz iD

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.70083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Ewa Wunsch und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Translational Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Nonprescription Drugs, Cholangitis, Sclerosing, Liver Cirrhosis, Biliary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Consumers, Health, Agriculture and Food Executive Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Non‐adherence to treatment may be one of the most important causes for the failure of therapy goals in autoimmune liver diseases (AILD). We aimed to assess factors related to non‐adherence in adult non‐transplanted patients with autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC). Approach and Results A cross‐sectional online survey was conducted in patients with AILD who were prescribed pharmacotherapy for liver disease. Adherence was defined as skipping their medication less than once a week and never reducing or stopping their medication themselves. Sociodemographic data were analyzed relating to medication and disease‐related factors in the context of adherence. Multivariable logistic regression analyses were used to identify factors associated with adherence while adjusting for known confounders. A total of 1097 patients with AILD were included: 444 patients with AIH, 377 with PBC and 276 with PSC. Patients with AIH were the most non‐adherent group (47%), in comparison to those suffering from PBC (29%), and PSC (38%). In multivariable logistic regression models, over‐the‐counter medication use was identified as one important common factor that was negatively associated with treatment adherence in all patients and most relevant in the case of the AIH group. Among standard treatments, steroids, though not azathioprine, were negatively associated with adherence in the AIH group. Conclusions This anonymous survey revealed high non‐adherence in patients with AILD, particularly those with AIH treated with steroids. Over‐the‐counter medication intake may reflect low treatment confidence in standard treatments and should be carefully assessed in patients with AILD in a clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis, AutoimmuneNonprescription DrugsCholangitis, SclerosingLiver Cirrhosis, BiliaryImmunosuppressive AgentsMedication AdherenceHumansFemaleMaleMiddle AgedCross-Sectional StudiesAdultAged

Stichwörter der Autor:innen

autoimmune hepatitisautoimmune liver diseasenon‐adherenceonline surveyover‐the‐counter medicationprimary biliary cholangitisprimary sclerosing cholangitisstandard therapysteroid treatmenttreatment adherence

Substanzen

Nonprescription DrugsImmunosuppressive Agents

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Translational Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • RARE-LIVER European Reference Network, Brussel, Belgium.
  • Institute of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Medicine and Martin Zeitz Centre for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Hamburg Center for Translational Immunology (HCTI), Hamburg, Germany.

ORCID-Profile: Piotr Milkiewicz

Förderung

  • Consumers, Health, Agriculture and Food Executive Agency

Zitieren

APA

Wunsch, E., Krause, L., Lohse, A. W., Schramm, C., Löwe, B., Uhlenbusch, N., Snijders, R., Willemse, J., Janik, M., Gevers, T. J. G., & Milkiewicz, P. (2025). Non‐Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over‐the‐Counter Medications. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70083

Vancouver

Wunsch E, Krause L, Lohse AW, Schramm C, Löwe B, Uhlenbusch N, et al. Non‐Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over‐the‐Counter Medications. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70083

BibTeX
@article{Wunsch2025,
  author = {Wunsch, Ewa and Krause, Linda and Lohse, Ansgar Wilhelm and Schramm, Christoph and Löwe, Bernd and Uhlenbusch, Natalie and Snijders, Romée and Willemse, José and Janik, Maciej and Gevers, Tom J G and Milkiewicz, Piotr},
  title = {Non‐Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over‐the‐Counter Medications},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.70083}
}
Kostenlos starten →